Aster Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$669K Buy
+15,672
New +$851K 0.14% 220
2026
Q1
Sell
-12,760
Closed -$1.22M 887
2025
Q4
$1.22M Buy
+12,760
New +$1.25M 0.53% 31
2025
Q2
Sell
-9,041
Closed -$938K 1079
2025
Q1
$938K Buy
+9,041
New +$910K 0.17% 156

Other funds holding BSX

Aster Capital Management's BSX Position: Q2 2026 in Review

Aster Capital Management opened a new position in Boston Scientific (BSX) in Q2 2026: 15,672 shares worth $669K. The stake represents 0.14% of the portfolio and ranks #220 among its holdings. This is a return to the name: Aster Capital Management previously reported a position in BSX as recently as Q4 2025.

Aster Capital Management first reported a position in BSX in Q1 2025 and has held it in 3 quarters since. The position peaked at $1.22M in Q4 2025. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Aster Capital Management held 15,672 shares of Boston Scientific worth $669K as of Q2 2026.
  • Boston Scientific was a new Aster Capital Management position in Q2 2026.
  • Boston Scientific made up 0.14% of Aster Capital Management's portfolio in Q2 2026, its #220 holding.
  • Aster Capital Management first reported a position in Boston Scientific in Q1 2025 and has held it in 3 quarters since.
  • Aster Capital Management's Boston Scientific position peaked at $1.22M in Q4 2025.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.